Timeline of human vaccines

From WikiProjectMed
Jump to navigation Jump to search

Vaccination-coverage-by-income-in.png

This is a timeline of the development of prophylactic human vaccines. Early vaccines may be listed by the first year of development or testing, but later entries usually show the year the vaccine finished trials and became available on the market. Although vaccines exist for the diseases listed below, only smallpox has been eliminated worldwide. The other vaccine-preventable illnesses continue to cause millions of deaths each year.[1] Currently, polio and measles are the targets of active worldwide eradication campaigns.

18th century

19th century

20th century

21st century

Under development

See also

Sources

  1. Vaccine Preventable Deaths and the Global Immunization Vision and Strategy, 2006--2015 Archived 9 December 2020 at the Wayback Machine, MMWR, CDC, 12 May 2006
  2. "Jenner's Breakthrough". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2020. Archived from the original on 6 June 2017. Retrieved 9 August 2020.
  3. Pasteur, L (1885). "Nota sobre la profilaxis del cólera por medio de inyecciones hipodérmicas de cultivo puro del bacilo virgula". El Siglo Med (in español). 32: 480.
  4. "Cholera: Ferrán's Vaccine". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2020. Archived from the original on 6 June 2017. Retrieved 9 August 2020.
  5. Historic Dates and Events Related to Vaccines and Immunization Archived 13 April 2016 at the Wayback Machine, Immunization Action Coalition, immunize.org, 30 December 2016
  6. "Another Success with Rabies Vaccine". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2020. Archived from the original on 6 June 2017. Retrieved 9 August 2020.
  7. "Antitoxin and Serum Therapy". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2020. Archived from the original on 6 June 2017. Retrieved 9 August 2020.
  8. "Basis for Typhoid Vaccination Is Established". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2020. Archived from the original on 6 June 2017. Retrieved 9 August 2020.
  9. Calmette, A (1922). L'infection bacillaire et la tuberculose chez l'homme et chez les animaux (in français) (2 ed.). Paris: Masson et Cie. Archived from the original on 2 February 2023. Retrieved 30 November 2022.
  10. "July 18: 90 Years of Tuberculosis Vaccination". The History of Vaccines. Philadelphia: The College of Physicians of Philadelphia. 2011. Archived from the original on 17 July 2014. Retrieved 9 August 2020.
  11. Plotkin, S.L. and Plotkin, S.A. "A short history of vaccination." In: Vaccines, Stanley A. Plotkin, Walter A. Orenstein, Paul A. Offit, eds. Elsevier Health Sciences, 2008, pp. 8.
  12. A Guide to Q fever and Q fever vaccination Archived 21 July 2018 at the Wayback Machine, CSL Biotherapies, 2009
  13. Patravale, Vandana; Dandekar, Prajakta; Jain, Ratnesh (2012). Nanoparticulate drug delivery perspectives on the transition from laboratory to market (1. publ. ed.). Oxford: Woodhead Pub. p. 212. ISBN 9781908818195. Archived from the original on 2 February 2023. Retrieved 30 November 2022.
  14. Schwartz, Jason L. (2012). "The First Rotavirus Vaccine and the Politics of Acceptable Risk". The Milbank Quarterly. 90 (2): 278–310. doi:10.1111/j.1468-0009.2012.00664.x. PMC 3460207. PMID 22709389.
  15. "Pneumococcal Vaccination: What Everyone Should Know | CDC". www.cdc.gov. 25 March 2021. Archived from the original on 12 November 2019. Retrieved 15 November 2021.
  16. Saavedra, María Del Carmen; Riera, Laura M.; Bottale, Alejandro J.; Mariani, Mauricio A.; Maiza, Andrea S.; Ambrosio, Ana María (2017). "[Stability of Candid#1 vaccine to prevent Argentine Hemorrhagic Fever]". Medicina. 77 (5): 353–357. ISSN 0025-7680. PMID 29044009. Archived from the original on 2 February 2023. Retrieved 30 November 2022.
  17. Cao Y, Bing Z, Guan S, Zhang Z, Wang X (2018). "Development of new hepatitis E vaccines". Human Vaccine & Immunotherapics. 14 (9): 2254–2262. doi:10.1080/21645515.2018.1469591. PMC 6183316. PMID 29708836.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. Mao, Qun-ying; Wang, Yiping; Bian, Lianlian; Xu, Miao; Liang, Zhenglun (May 2016). "EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD)". Expert Review of Vaccines. 15 (5): 599–606. doi:10.1586/14760584.2016.1138862. PMID 26732723. S2CID 45722352.
  19. Malaria vaccine approval first marred by efficacy question mark Archived 9 August 2016 at the Wayback Machine, Chemistry World, Maria Burke, 29 July 2015
  20. Sanofi's Dengue Vaccine Dengvaxia Gains Brazilian Approval Archived 1 June 2017 at the Wayback Machine, Zacks Equity Research, Zacks.com, 29 December 2015
  21. "Merck's Ervebo [Ebola Zaire Vaccine (rVSVΔG-ZEBOV-GP) live] Granted Conditional Approval in the European Union" (Press release). Merck. 11 November 2019. Archived from the original on 11 November 2019. Retrieved 11 November 2019 – via Business Wire.
  • keepkidshealthy claims "References: the CDC and Mandell: Principles and Practice of Infectious Diseases, 5th ed.," as its source.